Fucithalmic is a sterile 1%
aqueous sustained-release formulation of fusidic acid, preserved with
Fucithalmic is active against
Staphylococci, Streptococci, Neisseria, Haemophilus, Moraxella and
The sustained-release formulation
of Fucithalmic ensures a prolonged contact with the conjunctival sac. A
twice-daily application provides sufficient concentrations in all relevant
tissues of the eye. Fucithalmic penetrates well into the aqueous humour.
Bacterial eye infections caused
by susceptible organisms in conjunctivitis, blepharitis, sty, keratitis,
dacryocystitis and in connection with removal of foreign bodies.
One drop to be instilled into the
eye twice daily. Treatment should be continued for at least two days after
the eye appears normal.
Hypersensitivity to any component
Should not be used when contact
lenses are being worn.
Pregnancy and lactation
There is inadequate evidence of
safety in human pregnancy. Animal studies and many years of clinical
experience have suggested that fusidic acid is devoid of teratogenic
effects. Safety in nursing mothers has not been established.
Transient stinging may occur.
Fucithalmic has a very low allergenic potential.
Fucithalmic is a ready-for-use
preparation and should, therefore not be mixed with other ingredients or
Store at controlled room
temperature ( 15°C - 25°C )
Discard 30 days after opening.